Eli Lilly and Co (NYSE:LLY)
| 331.07 Delayed Data As of Mar 22 |  -0.01 / -0.00%Today’s Change | 276.83 Today|||52-Week Range 384.44 | -9.50% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $313.8B |
Company Description
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Contact Information
Eli Lilly & Co. Lilly Corporate Center Indianapolis Indiana 46285 |
Employees
Shareholders
| Mutual fund holders | 40.82% |
| Other institutional | 32.74% |
| Individual stakeholders | 11.67% |
Top Executives
| David A. Ricks | Chairman, President & Chief Executive Officer |
| Ruth Gimeno | Vice President |
| Anat Ashkenazi | Chief Financial Officer & Executive Vice President |
| Daniel M. Skovronsky | Executive VP, Chief Scientific & Medical Officer |
| Diogo Rau | Senior VP, Chief Information & Digital Officer |
